Compare MGTX & VYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MGTX | VYX |
|---|---|---|
| Founded | 2015 | 1881 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 994.1M |
| IPO Year | 2018 | 1996 |
| Metric | MGTX | VYX |
|---|---|---|
| Price | $9.22 | $8.15 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 6 |
| Target Price | ★ $27.75 | $12.67 |
| AVG Volume (30 Days) | 819.2K | ★ 2.5M |
| Earning Date | 11-12-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 33.02 | N/A |
| EPS | ★ 1.30 | N/A |
| Revenue | $81,391,000.00 | ★ $7,156,000,000.00 |
| Revenue This Year | $314.19 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $7.09 | ★ N/A |
| Revenue Growth | ★ 144.57 | 15.29 |
| 52 Week Low | $6.62 | $6.02 |
| 52 Week High | $15.35 | $12.02 |
| Indicator | MGTX | VYX |
|---|---|---|
| Relative Strength Index (RSI) | 31.90 | 58.88 |
| Support Level | $8.84 | $7.51 |
| Resistance Level | $10.06 | $8.46 |
| Average True Range (ATR) | 0.52 | 0.38 |
| MACD | 0.01 | 0.18 |
| Stochastic Oscillator | 6.12 | 77.34 |
MeiraGTx Holdings PLC is a vertically integrated, clinical-stage genetic medicines company focused on developing targeted therapies for diseases with high unmet need, including radiation-induced xerostomia, Parkinson's disease, and AIPL1-associated retinal dystrophy. The company's pipeline is supported by end-to-end in-house manufacturing capabilities, including GMP viral vector production, plasmid manufacturing, and quality control, enabling development from IND to commercial supply. It also utilizes proprietary platforms in viral vector optimization and riboswitch-based gene regulation to enhance efficacy and reduce dosage. The company operates in the United States, the United Kingdom, and the European Union.
NCR Voyix Corp is a company providing services of digital commerce solutions for retail, restaurant, and digital banking. The company operates in two reportable segments: Retail, and Restaurants. The Retail segment provides software solutions for retailers of all sizes, enhancing operational efficiency and customer experience. The Restaurants segment offers end-to-end technology solutions for food service establishments, improving operational efficiency, and customer satisfaction, and reducing costs. The company derives maximum revenue from Retail segment. Geographically, the company operates in United States, Americas (excluding United States), Europe, Middle East and Africa, and Asia Pacific. It derives maximum revenue from United States.